Accessibility Menu
Ctt Pharmaceutical logo

Ctt Pharmaceutical(OTC) CTTH

Current Price$0.07
Market Cap$3.94MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2014)-84%
5 Year+27%
1 Year+94%
1 Month-18%
Ctt Pharmaceutical last closing stock price
MetricPriceDate
Last closeUSD 0.072026-07-24
Ctt Pharmaceutical stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.072026-07-17
1 month-17.5%USD 0.082026-06-23
3 month-6.71%USD 0.072026-04-24
Year to date+9.81%USD 0.062025-12-31
1 year+94.12%USD 0.032025-07-24
3 year+560%USD 0.012023-07-25
5 year+26.92%USD 0.052021-07-23
Since inception-84.29%USD 0.422014-09-11

Ctt Pharmaceutical Financials at a Glance

Market Cap

$3.94MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$157.58K

EPS (TTM)

-$0.00

P/E Ratio

-24.44

Dividend

$0.00

Beta (Volatility)

-0.56 (Low)

Price

$0.07

Volume

17,783

Open

$0.07

Previous Close

$0.07

Daily Range

$0.07 - $0.07

52-Week Range

$0.03 - $0.10

Estimated Earnings Date

N/A

CTTH News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ctt Pharmaceutical

CTT Pharmaceutical Holdings, Inc. is focused on developing innovative oral drug delivery systems for pain management and treatment. The company specializes in fast-dissolving drug delivery systems, particularly utilizing cannabis extracts to provide alternatives to traditional methods of consumption.

Products and Services
  • Advanced oral delivery thin wafers infused with cannabis extracts
  • Innovative pain management solutions
  • Research and development in drug delivery technologies
Growth Outlook
  • Market demand for cannabis-based therapies is increasing
  • Potential expansion into new therapeutic areas
  • Focus on enhancing product efficacy and delivery methods
Financial Highlights
  • Recent quarterly net income of -$84,674
  • Trailing twelve months (TTM) revenue of $0
  • Cash and cash equivalents of $7,089 as of March 31, 2026
CTT Pharmaceutical Holdings, Inc. operates in the healthcare sector, specifically within the medical pharmaceuticals industry. The company is based in Tampa, Florida, and is dedicated to creating effective alternatives for pain management through its patented technologies. Despite recent financial challenges, the company is positioned in a growing market with increasing interest in cannabis-based treatments. The innovative approach to drug delivery systems may attract attention from investors looking for opportunities in the evolving pharmaceutical landscape.
AI Generated • Jun 28, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

1

CEO

Ryan Khouri

Website

www.cttpharmaceuticals.com

Headquarters

Tampa, FL 33624, US

CTTH Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-242.12%

Return on Capital

-171.37%

Return on Assets

-206.81%

Earnings Yield

-4.09%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.94MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

59.72M

Volume

17.78K

Avg. Volume

16.20K

Financials (TTM)

Gross Profit

-$6.54K

Operating Income

-$115.69K

EBITDA

-$109.15K

Operating Cash Flow

-$63.15K

Capital Expenditure

$0.00

Free Cash Flow

-$63.15K

Cash & ST Invst.

$7.09K

Total Debt

$18.81K

Ctt Pharmaceutical Performance Analysis

Ctt Pharmaceutical annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 0N/A
20232023-12-31USD 0N/A
20242024-12-31USD 0N/A
20252025-12-31USD 0N/A
Ctt Pharmaceutical sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30N/A
Q32025-09-30N/A
Q42025-12-31N/A
Q12026-03-31N/A
Ctt Pharmaceutical annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.00-59.3%
20232023-12-31USD -0.00-27.3%
20242024-12-31USD -0.00500.0%
20252025-12-31USD -0.00-43.7%
Ctt Pharmaceutical sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3093.8%
Q32025-09-30400.0%
Q42025-12-31-533.3%
Q12026-03-31-7.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$1.70K

-6.4%

Gross Margin

0.00%

N/A

Market Cap

$3.94MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$3.94M

N/A

Employees

1

N/A

Net Income

-$84.67K

-2.0%

EBITDA

-$76.64K

+5.8%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$7.09K

-85.4%

Total Debt

$18.81K

+8.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$18.81K

+8.1%

Return on Assets

-2.07%

N/A

Return on Invested Capital

-2.80%

N/A

Free Cash Flow

-$19.07K

+39.2%

Operating Cash Flow

-$19.07K

+39.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PCYNProcyon Corporation
$0.26+0.00%
MJNAMedical Marijuana, Inc.
$0.00+0.00%
HBRMHerborium Group, Inc.
$0.00+0.00%
EDXCEndexx Corporation
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
SOFISoFi Technologies
$16.46-0.01%
TAT&T
$24.13+0.05%

Questions About CTTH

What is the current price of Ctt Pharmaceutical?

Ctt Pharmaceutical is trading at $0.07 per share.

What is the 52-week range for Ctt Pharmaceutical?

Over the past 52 weeks, Ctt Pharmaceutical has traded between $0.03 and $0.10.

How much debt does Ctt Pharmaceutical have?

As of the most recent reporting period, Ctt Pharmaceutical reported total debt of $18.81K.

How much cash does Ctt Pharmaceutical have on hand?

Ctt Pharmaceutical reported $7.09K in cash and cash equivalents in its most recent financial results.

What is Ctt Pharmaceutical’s dividend yield?

Ctt Pharmaceutical does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services